July 8, 2022

Comirnaty Receives Full FDA Approval for Expanded Age Group

Read More
July 6, 2022

Mylan Recalls One Lot of Insulin Glargine

Read More
July 6, 2022

Pharmacists Now Able to Prescribe Paxlovid

Read More
July 1, 2022

Brand Medications with Generic Alternatives Anticipated to be Approved in July

Read More
June 30, 2022

Copiktra May Increase Risk for Cancer Patients

Read More
June 30, 2022

Zelnorm Withdrawn from Market

Read More
June 29, 2022

FDA Updates Evusheld Dosing Recommendations

Read More
June 24, 2022

Breyanzi Wins Broader Use in Large B-Cell Lymphoma Treatment

Read More
June 23, 2022

Tafinlar and Mekinist Approved to Treat Solid Tumors

Read More
June 22, 2022

Merck’s Pneumococcal Vaccine Now Indicated for Children

Read More
June 22, 2022

Zulresso Indicated for Postpartum Depression in Adolescents

Read More
June 17, 2022

Skyrizi Granted New Indication for Crohn’s Disease

Read More